Background: Plaque debulking prior stent implantation reduces the restenosis rate and the restenosis-related events during the short-term clinical outcome. However, the long-term results are not fully characterized. Aims: To examine the long-term clinical outcome in a consecutive series of patients (pts) undergoing successful, elective, native-vessel directional coronary atherectomy (DCA) followed by stent implantation. Methods: Between May 1994 and December 2000, 298 pts with symptomatic coronary artery disease and/or objective evidence of myocardial ischemia (71% unstable angina) were treated by DCA followed by elective stenting. The pts were prospectively evaluated clinically [myocardial infarction (MI), death, target lesion revascularization (TLR)] after one month, six months and every six months and angiographically after six months or earlier in case of recurrence of symptoms/ischemia. Results: The combined approach of DCA followed by stent implantation was successfully performed in 272 out of 298 pts (primary success rate 91%)-283 lesions (87% LAD, 3% CX, 10% RCA). Sixty-nine pts (25%) had multivessel disease and 40 pts (15%) had diabetes. The immediate results were highly satisfactory (Minimal Luminal Diameter: 0.70+0.28 mm at baseline, 2.93+0.48 mm after DCA+stent; p 0.05) with very few periprocedural and in-hospital early major complications (2 deaths and 1 MI out of 272 pts; 1.1%). Angiographic follow-up was performed in 196 pts-205 lesions treated (72%) at 7±3 months (range 1-24 months) with a Loss Index of 0.37+0.32 and an angiographic (> 50%) restenosis rate of 14.7%. In a clinical follow-up of 23.5+13.8 months (range 1-80 months), non-fatal MI/death was observed in 4.2% and TLR at any time was needed in 15.4% of pts (Combined End-point: 17.4%). Conclusions: Plaque debulking by DCA followed by elective stenting is a relatively safe and effective procedure that ensures a good clinical long-term outcome.

Long-term clinical outcome after directional coronary atherectomy followed by stem implantation

GNECCHI, MASSIMILIANO;
2001-01-01

Abstract

Background: Plaque debulking prior stent implantation reduces the restenosis rate and the restenosis-related events during the short-term clinical outcome. However, the long-term results are not fully characterized. Aims: To examine the long-term clinical outcome in a consecutive series of patients (pts) undergoing successful, elective, native-vessel directional coronary atherectomy (DCA) followed by stent implantation. Methods: Between May 1994 and December 2000, 298 pts with symptomatic coronary artery disease and/or objective evidence of myocardial ischemia (71% unstable angina) were treated by DCA followed by elective stenting. The pts were prospectively evaluated clinically [myocardial infarction (MI), death, target lesion revascularization (TLR)] after one month, six months and every six months and angiographically after six months or earlier in case of recurrence of symptoms/ischemia. Results: The combined approach of DCA followed by stent implantation was successfully performed in 272 out of 298 pts (primary success rate 91%)-283 lesions (87% LAD, 3% CX, 10% RCA). Sixty-nine pts (25%) had multivessel disease and 40 pts (15%) had diabetes. The immediate results were highly satisfactory (Minimal Luminal Diameter: 0.70+0.28 mm at baseline, 2.93+0.48 mm after DCA+stent; p 0.05) with very few periprocedural and in-hospital early major complications (2 deaths and 1 MI out of 272 pts; 1.1%). Angiographic follow-up was performed in 196 pts-205 lesions treated (72%) at 7±3 months (range 1-24 months) with a Loss Index of 0.37+0.32 and an angiographic (> 50%) restenosis rate of 14.7%. In a clinical follow-up of 23.5+13.8 months (range 1-80 months), non-fatal MI/death was observed in 4.2% and TLR at any time was needed in 15.4% of pts (Combined End-point: 17.4%). Conclusions: Plaque debulking by DCA followed by elective stenting is a relatively safe and effective procedure that ensures a good clinical long-term outcome.
2001
European Heart Journal
Cardiovascular & Hematology Research covers all levels of investigation into the normal and pathogenic functions of the heart, vasculature, and soluble blood components. Cell biology of vascular tissue and formed elements of blood, biochemical regulation of thrombosis, therapeutic strategies for treatment of cardiac and vascular diseases are also considered. Resources on hematologic oncology are excluded and are placed in the Oncogenesis & Cancer Research category.
Sì, ma tipo non specificato
Inglese
contributo
XXIII Annual Congress of the European Society of Cardiology
1-5 Settembre 2001
Stockholm
Internazionale
STAMPA
22
659
659
STENT IMPLANTATION; PLAQUE DEBULKING; CLINICAL OUTCOME
none
Ardissino, D; Boschetti, E; Repetto, A; Brambilla, N; Bramucci, E; Ferrario, M; Canosi, U; Angoli, L; Gnecchi, Massimiliano; Tavazzi, L.
273
info:eu-repo/semantics/conferenceObject
10
4 Contributo in Atti di Convegno (Proceeding)::4.1 Contributo in Atti di convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/456351
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact